CR20190402A - Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla - Google Patents
Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararlaInfo
- Publication number
- CR20190402A CR20190402A CR20190402A CR20190402A CR20190402A CR 20190402 A CR20190402 A CR 20190402A CR 20190402 A CR20190402 A CR 20190402A CR 20190402 A CR20190402 A CR 20190402A CR 20190402 A CR20190402 A CR 20190402A
- Authority
- CR
- Costa Rica
- Prior art keywords
- cinitapride
- simeticone
- rapid
- release composition
- preparing same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica de administración oral, bajo la forma de cápsulas con contenido líquido, que comprende una combinación a dosis fija de Cinitaprida tartrato y Simeticona junto con al menos un agente surfactante y opcionalmente uno o más excipientes farmacéuticamente aceptables, y el proceso para obtener dicha composición.The present invention relates to an orally-administered pharmaceutical composition, in the form of capsules with liquid content, which comprises a fixed-dose combination of cinitapride tartrate and simeticone together with at least one surfactant and, optionally, one or more pharmaceutically acceptable excipients, and to the method for obtaining said composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2017001714A MX2017001714A (es) | 2017-02-07 | 2017-02-07 | Composicion de liberacion rapida de cinitaprida y simeticona y proceso para prepararla. |
PCT/IB2018/050528 WO2018146575A1 (es) | 2017-02-07 | 2018-01-29 | Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20190402A true CR20190402A (es) | 2019-09-20 |
Family
ID=63108046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20190402A CR20190402A (es) | 2017-02-07 | 2018-01-29 | Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla |
Country Status (10)
Country | Link |
---|---|
AR (1) | AR110797A1 (es) |
BR (1) | BR112019015989A2 (es) |
CL (1) | CL2019001944A1 (es) |
CO (1) | CO2019008347A2 (es) |
CR (1) | CR20190402A (es) |
DO (1) | DOP2019000190A (es) |
EC (1) | ECSP19051198A (es) |
MX (1) | MX2017001714A (es) |
PE (1) | PE20191491A1 (es) |
WO (1) | WO2018146575A1 (es) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6676933B2 (en) * | 2001-05-23 | 2004-01-13 | Osmotica Corp. | Pharmaceutical composition containing mosapride and pancreatin |
EP1596838A2 (en) * | 2003-02-11 | 2005-11-23 | Torrent Pharmaceuticals Ltd | Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent |
EP1817012A2 (en) * | 2004-11-24 | 2007-08-15 | Merck & Co., Inc. | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
WO2009066146A2 (en) * | 2007-11-19 | 2009-05-28 | Cadila Pharmaceuticals Ltd. | Stable solutions of sparingly soluble actives |
-
2017
- 2017-02-07 MX MX2017001714A patent/MX2017001714A/es unknown
-
2018
- 2018-01-29 WO PCT/IB2018/050528 patent/WO2018146575A1/es active Application Filing
- 2018-01-29 CR CR20190402A patent/CR20190402A/es unknown
- 2018-01-29 PE PE2019001412A patent/PE20191491A1/es unknown
- 2018-01-29 BR BR112019015989-4A patent/BR112019015989A2/pt active Search and Examination
- 2018-02-06 AR ARP180100282A patent/AR110797A1/es unknown
-
2019
- 2019-07-11 CL CL2019001944A patent/CL2019001944A1/es unknown
- 2019-07-16 EC ECSENADI201951198A patent/ECSP19051198A/es unknown
- 2019-07-19 DO DO2019000190A patent/DOP2019000190A/es unknown
- 2019-07-30 CO CONC2019/0008347A patent/CO2019008347A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112019015989A2 (pt) | 2020-03-31 |
DOP2019000190A (es) | 2019-10-15 |
PE20191491A1 (es) | 2019-10-21 |
CL2019001944A1 (es) | 2019-12-06 |
MX2017001714A (es) | 2018-08-06 |
AR110797A1 (es) | 2019-05-02 |
ECSP19051198A (es) | 2019-07-31 |
WO2018146575A1 (es) | 2018-08-16 |
CO2019008347A2 (es) | 2019-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016001411A1 (es) | Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina. | |
EP3706774A4 (en) | GLP-2 ANALOGUES AND PEPTIBODIES FOR USE BEFORE, DURING OR AFTER SURGICAL PROCEDURE | |
CL2019002218A1 (es) | Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular. | |
ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
CO2017002682A2 (es) | Composiciones y métodos para recubrimientos cannabinoides para uso en la entrega de fármacos | |
CO6640264A2 (es) | Combinación de gránulos cargados activos con activos adicionales | |
AR115913A1 (es) | Formas de dosificación oral biodisponibles, uso, métodos | |
NZ704014A (en) | Formulations and methods of manufacturing formulations for use in colonic evacuation | |
CL2018003682A1 (es) | Composición farmacéutica oral, que comprende un agente farmacéuticamente activo, al menos un polímero catiónico bioadhesivo y al menos dos polímeros aniónicos. | |
PH12016500414B1 (en) | Solid preparation containing choline alfoscerate and method for preparing same | |
BR112015022946A2 (pt) | forma de dosagem de cápsula de gelatina macia farmacêutica com goma guar modificada | |
JP2017523149A5 (es) | ||
CR20190402A (es) | Composición de liberación rápida de cinitaprida y simeticona y proceso para prepararla | |
MX2015003956A (es) | Composicion farmaceutica que comprende bromuro de pinaverio micronizado y simeticona. | |
AR096223A1 (es) | Pastilla de nicotina para administración oral | |
CR20190290A (es) | Composición mejorada de lansoprazol y simeticona y proceso para prepararla | |
CO2019013645A2 (es) | Dropropizina en combinación con ambroxol en la forma farmacéutica de jarabe y tabletas | |
JP2017515849A5 (es) | ||
UY38028A (es) | Combinación farmacéutica en la forma de comprimidos en bicapa que comprende ketorolaco trometamina y su uso para el tratamiento del dolor | |
AR108371A1 (es) | Comprimidos de metilfenidato de liberación retardada | |
TR201720510A2 (tr) | Orally disintegrating tablet formulations of ivabradine | |
UA97982U (uk) | Лікарський засіб седативної дії у вигляді таблеток | |
PH12018550075A1 (en) | An oral osmotic pharmaceutical composition of vildagliptin | |
UA91282U (uk) | Фармацевтичний продукт, що має виражену антигестагенну дію | |
RS20130177A1 (en) | Slow-release PHARMACEUTICAL PRODUCT AND DOSAGE PROCEDURE |